Bismuth quadruple and concomitant therapies yielded the highest eradication rates for initial treatment of Helicobacter ...

Although obinutuzumab has not yet received FDA approval in lupus nephritis, findings from a recent survey conducted by ...

U.S. officials have rejected proposed amendments to WHO’s International Health Regulations citing concerns over vague wording ...

A phase 2b study evaluating repibresib gel in nonsegmental vitiligo did not meet its primary endpoint and an ongoing ...

Daily doses of obicetrapib over 52 weeks led to significant reductions in plasma p-tau217 and other Alzheimer’s disease ...

The FDA has approved the SetPoint System, a vagus nerve stimulator from SetPoint Medical, for the treatment of rheumatoid ...

Once-weekly tirzepatide conferred a similar cardiovascular risk as once-weekly dulaglutide in adults with type 2 diabetes and ...

The level of neighborhood deprivation was associated with cognitive speed concerns for individuals on the cusp of midlife, ...

In this Healio Video Perspective from the American Society of Retina Specialists annual meeting, Sunir J. Garg, MD, FACS, ...

Exercise-based cardiac rehabilitation may improve symptom burden, exercise capacity and health-related quality of life for ...

AbbVie released positive topline data from its phase 3 UP-AA trial demonstrating safety and efficacy for upadacitinib for ...

V Foundation for Cancer Research has named Diana Hargreaves, PhD, a 2025 All-Star Translational Award Program grantee, ...